Val Cipriani

6 days ago | investorschronicle.co.uk | Val Cipriani

Pension rules have changed numerous times in recent years. When this happens, or when people think another shift is on the way, many rush to take money out of their pension pots in order to avoid a possible future tax charge. In some cases, this can make sense. The changes to inheritance tax (IHT) announced by the government in last year’s Autumn Budget are prompting a number of people to rethink their estate planning, for example.

1 week ago | investorschronicle.co.uk | Val Cipriani

Since an early age, I have been collecting sporting memorabilia: my hobby first began at cricket matches, where I would wait for players to autograph items after the close of play. I have a vast collection – a mix of items either collected personally at little cost, purchased through online auction sites or in person at specialised sporting auctions.

1 week ago | investorschronicle.co.uk | Val Cipriani

Back to work after maternity leave or a personal break? Prioritise your emergency savings and pensionPublished on May 6, 2025Be it to take care of your children and spend more time with your family, or to work on a side project or for another reason, taking a career break can be fulfilling from a personal perspective. However, it can be less helpful for your pockets.

2 weeks ago | investorschronicle.co.uk | Val Cipriani

Investment Risk: MediumInvestment Style: QualityInvestment Timescale: Long termThe end of US exceptionalism is the talk of the town. It’s too soon to tell whether this crisis will morph into a seismic change that permanently reshapes global markets, but investors can’t be faulted for looking at other regions with increased enthusiasm. If you are thinking of topping up your domestic exposure, Edinburgh Investment Trust (EDIN) offers access to UK quality companies at an attractive discount.

2 weeks ago | investorschronicle.co.uk | Val Cipriani

Lack of clarity on tariffs and regulations means biotech stocks and funds are strugglingPublished on May 1, 2025Shares in biotechnology investment trusts have fallen sharply this year, as the sector has contended with an uncertain environment under Donald Trump’s presidency. Between the beginning of the year and 28 April, biotech trusts’ share prices were down by between 11 per cent and 20 per cent, despite a partial bounce back in the second half of April.